Amoebiasis
Full paraphrased clinical guide to intestinal amoebiasis, amoebic liver abscess, diagnosis, treatment, and follow-up.
Seek urgent care
- Bloody or mucus diarrhoea with dehydration, severe abdominal pain, fever, altered mental status, or inability to drink.
- Right upper abdominal pain, tender enlarged liver, jaundice, respiratory symptoms, or suspected liver abscess.
- Symptoms not improving after appropriate dysentery treatment, especially after shigellosis treatment failure.
Overview
Amoebiasis is a parasitic infection caused by Entamoeba histolytica and transmitted by the faecal-oral route through contaminated food or water.
Many carriers have no symptoms. In a smaller proportion, the parasite invades the colon and causes amoebic dysentery.
The parasite can also spread through the bloodstream and form abscesses, most commonly in the liver.
Amoebic dysentery
- Diarrhoea may contain red blood and mucus.
- Abdominal pain and tenesmus can occur.
- Fever is absent or moderate in many cases.
- Assess for dehydration and nutritional risk.
Amoebic liver abscess
- Consider liver abscess with fever, right upper abdominal pain, tender enlarged liver, or symptoms that suggest extra-intestinal spread.
- Respiratory discomfort or referred shoulder pain can occur when the abscess irritates nearby structures.
- Point-of-care ultrasound can support diagnosis only when performed and interpreted by trained clinicians.
Investigations
- For amoebic dysentery, confirmation requires identification of mobile Entamoeba histolytica trophozoites in a fresh stool sample.
- Finding cysts alone should not lead to amoebiasis treatment because many carriers are asymptomatic and cyst microscopy may not prove invasive disease.
- In dysentery, shigellosis is more common and should be considered first in many settings.
- For amoebic liver abscess, indirect haemagglutination or ELISA may support diagnosis when available.
- Point-of-care ultrasound can help evaluate liver and spleen lesions only when performed and interpreted by trained clinicians, with expert support when needed.
Treatment
- Treat dehydration with ORS or IV fluids according to severity and maintain nutrition.
- If laboratory confirmation is unavailable, first-line treatment for dysentery is shigellosis treatment. Treat amoebiasis if correct shigellosis treatment has been ineffective.
- Liver abscess requires clinical follow-up and imaging or referral where available. Drainage is reserved for selected situations, such as diagnostic uncertainty, poor response, high rupture risk, or specialist advice.
- Avoid alcohol during nitroimidazole treatment and check contraindications, pregnancy status, interactions, and local protocol.
| Medicine | Dose and duration |
|---|---|
| Tinidazole PO | Children: 50 mg/kg once daily for 3 days, maximum 2 g/day. Adults: 2 g once daily for 3 days. |
| Metronidazole PO | Children: 15 mg/kg three times daily for 5 days. Adults: 500 mg three times daily for 5 days. |
| Medicine | Dose and duration |
|---|---|
| Tinidazole PO | Same dose as dysentery, for 5 days. |
| Metronidazole PO | Same dose as dysentery, for 5 to 10 days. |
Prevention, complications, and handover
- Prevention depends on safe water, sanitation, hand hygiene, safe food handling, and avoiding faecal contamination of food and water.
- Complications include severe dehydration, colitis, perforation, liver abscess rupture, pleuropulmonary extension, secondary bacterial infection, and sepsis.
- Refer urgently for suspected liver abscess with severe illness, jaundice, respiratory symptoms, peritonitis signs, persistent fever, shock, or failure to improve.
- Handover should include stool findings, dehydration status, prior shigellosis treatment and response, stool microscopy result, liver findings, ultrasound/serology results, medicine regimen, ability to drink, complications, and follow-up plan.
Medicines in this guide
Source
MSF Clinical guidelines - Diagnosis and treatment manual (December 2024)
This page is a paraphrased clinician-oriented guide derived from the source topic on PDF page 118. Medicine-specific details should be checked against local protocol and the linked drug-information pages.
